VERONESE, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.333
EU - Europa 233
AS - Asia 168
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 2.736
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.332
CN - Cina 141
FI - Finlandia 64
DE - Germania 51
UA - Ucraina 42
IT - Italia 20
SE - Svezia 20
FR - Francia 15
VN - Vietnam 13
GB - Regno Unito 12
IN - India 7
IE - Irlanda 4
PL - Polonia 3
IR - Iran 2
NL - Olanda 2
TR - Turchia 2
CA - Canada 1
EU - Europa 1
ID - Indonesia 1
JP - Giappone 1
PE - Perù 1
TW - Taiwan 1
Totale 2.736
Salva come PNG Salva come JPEG
Città #
Fairfield 352
Chandler 245
Jacksonville 238
Woodbridge 223
Houston 208
Ann Arbor 170
Ashburn 148
Seattle 139
Wilmington 132
Cambridge 98
Princeton 70
Beijing 38
Nanjing 38
Roxbury 36
Helsinki 27
San Diego 25
Dong Ket 13
Boardman 11
Medford 9
Hebei 8
Nanchang 8
Indiana 7
Norwalk 7
Venice 7
Guangzhou 6
Changsha 5
Ogden 5
Des Moines 4
Dublin 4
Jinan 4
London 4
Mestre 4
Munich 4
Auburn Hills 3
Bangalore 3
Dortmund 3
Jiaxing 3
Shenyang 3
Tianjin 3
Acton 2
Augusta 2
Borås 2
Buffalo 2
Padova 2
Portland 2
Shanghai 2
Trento 2
Ardabil 1
Barlassina 1
Cempaka-udik 1
Chicago 1
Cinisello Balsamo 1
Cordova 1
Enschede 1
Falkenstein 1
Fuzhou 1
Hangzhou 1
Istanbul 1
Kelsterbach 1
Kharkiv 1
Kilburn 1
Leawood 1
Lima 1
Los Angeles 1
Monmouth Junction 1
Montreal 1
New Bedfont 1
New York 1
Paris 1
Redmond 1
San Antonio 1
San Francisco 1
Tokyo 1
Uppsala 1
Totale 2.358
Salva come PNG Salva come JPEG
Nome #
Synthesis and biological in vitro evaluation of novel PEG-psoralen conjugates 129
Gene delivery as a new therapeutic approach 118
Polyphosphazene membranes and microspheres in periodontal diseases and implant surgery 115
Physico-Chemical and Biological Properties of Monofunctional Hydroxy Teriminating Poly(N-Vinylpyrrolidone) Conjugated Superoxide Dismutase 108
Immunological properties of uricase conjugated to neutral soluble polymers 107
Bioconjugation in pharmaceutical chemistry 102
Therapeutic proteins: a comparison of chemical and biological properties of uricase conjugated to linear or branched poly(ethylene glycol) and poly(N-acryloylmorpholine) 101
Synthesis, characterization and preliminary cytotoxicity assays of poly(ethylene glycol)-malonato-Pt-DACH conjugates 99
New synthetic polymers for enzyme and liposome modification 91
PEG-epirubicin conjugates with high drug loading 88
Modification of physico-chemical and biopharmaceutical properties of superoxide dismutase by conjugation to the co-polymer of divinyl ether and maleic anhydride 87
PEG-metronidazole conjugates: synthesis, in vitro and in vivo properties 85
Preparation and characterization of poly(ethylene glycol) vinyl sulfone 82
Biopolymeric modification of superoxide dismutase (mPEG-SOD) to prevent muscular ischemia-reperfusion damage 81
Biochemical modifications of avidin improve pharmacokinetics and biodistribution, and reduce immunogenicity 76
Detection of sites of infection in mice using 99mTc-labeled PN(2)S-PEG conjugated to UBI and 99mTc-UBI: a comparative biodistribution study. 74
Polyphosphazene microspheres for insulin delivery 74
Synthesis and characterization of poly(2-ethyl 2 oxazoline)-conjugates with proteins and drugs: suitable alternatives to PEG-conjugates? 72
Peg-doxorubicin conjugates with high loading 71
End functionalized PVP as new oligomer for enzyme modification 70
Polyorganophosphazene Microspheres for Drug Release: Polymer Synthesis, Microsphere Preparation, In Vitro and In Vivo Naproxen Release. 70
New synthetic amphiphilic polymers for steric protection of liposomes in vivo 68
Poly(N-acryloylmorpholine) can be used in alternative to poly(ethylene glycol) for protein modification. 66
Highly efficient technetium-99m labeling procedure based on the conjugation of N-[N-(3-diphenylphosphinopropionyl)glycyl]cysteine ligand with poly(ethylene glycol) 62
Preparation and characterisation of polyphosphazene-based controlled release systems for naproxen 59
Pegylation of the antimicrobial peptide nisin A: problem and perspectives 57
New active poly(ethylene glycol) derivative for amino coupling 56
PEGylation of growth hormone-releasing hormone (GRF) analogues 56
Peripheral nerve repair using a poly(organo)phosphazene tubular prostheses 55
Poly(ethylene glycol) (PEG)- malonato-Pt DACH conjugates 52
A new method for high selective TGase-mediated PEGylation of salmon calcitonin and human growth hormone 51
Selective alkylation and acylation of alpha and epsilon amino groups with PEG in a somatostatin analogue: Tailored chemistry for optimized bioconjugates 48
Distribution of catalase, ribonuclease and superoxide dismutase modified by monomethoxy (polyethylene glycol) into rat central lymph and lymphatic nodes 46
Drug Delivery System 44
Protein, peptide and non-peptide drug PEGylation for therapeutical application: a review 41
Anchimeric assistance effect on regloselective hydrolysis of branched PEGs: a mechanistic investigation 35
Rapporti di scambio idrico tra corsi d'acqua e falde nell'Alta Pianura Veneta 26
Nitric oxide modulates pro- and anti-apoptotic properties of chemotherapy agents: the case of NO-pegylated epirubicin 23
Totale 2.745
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.488
article - articoli 7.414
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 88
patent - brevetti 0
selected - selezionate 0
volume - volumi 572
Totale 16.562
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019213 0 0 0 0 0 0 0 0 0 42 94 77
2019/2020574 101 13 12 34 52 52 44 63 52 70 41 40
2020/2021419 11 42 5 19 26 60 6 49 80 39 56 26
2021/2022446 7 50 72 17 19 30 13 49 32 7 67 83
2022/2023436 70 56 2 41 77 63 0 45 50 9 21 2
2023/2024138 6 38 25 14 4 1 24 9 7 10 0 0
Totale 2.745